Evidence map›Paper›PMID 36732019›Full record

ArticleLife science alliance2023

Epigenetic signals that direct cell type-specific interferon beta response in mouse cells.

Markus Muckenhuber, Isabelle Seufert, Katharina Müller-Ott, Jan-Philipp Mallm, Lara C Klett, Caroline Knotz, Jana Hechler, Nick Kepper, Fabian Erdel, Karsten Rippe

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Transcriptional control of interferon-stimulated genes.The Journal of biological chemistry · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Enhancing sensitivity and versatility of Tn5-based single cell omics.Frontiers in epigenetics and epigenomics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Markus MuckenhuberDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.ORCID https://orcid.org/0000-0003-1897-2329
Isabelle SeufertDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.ORCID https://orcid.org/0000-0001-9811-3836
Katharina Müller-OttDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-1918-1046
Jan-Philipp MallmDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-7059-4030
Lara C KlettDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.
Caroline KnotzDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.
Jana HechlerDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.
Nick KepperDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.
Fabian ErdelDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.ORCID https://orcid.org/0000-0003-2888-7777
Karsten RippeDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany karsten.rippe@dkfz.de.ORCID https://orcid.org/0000-0001-9951-9395
German Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antiviral response induced by type I interferon (IFN) via the JAK-STAT signaling cascade activates hundreds of IFN-stimulated genes (ISGs) across human and mouse tissues but varies between cell types. However, the links between the underlying epigenetic features and the ISG profile are not well understood. We mapped ISGs, binding sites of the STAT1 and STAT2 transcription factors, chromatin accessibility, and histone H3 lysine modification by acetylation (ac) and mono-/tri-methylation (me1, me3) in mouse embryonic stem cells and fibroblasts before and after IFNβ treatment. A large fraction of ISGs and STAT-binding sites was cell type specific with promoter binding of a STAT1/2 complex being a key driver of ISGs. Furthermore, STAT1/2 binding to putative enhancers induced ISGs as inferred from a chromatin co-accessibility analysis. STAT1/2 binding was dependent on the chromatin context and positively correlated with preexisting H3K4me1 and H3K27ac marks in an open chromatin state, whereas the presence of H3K27me3 had an inhibitory effect. Thus, chromatin features present before stimulation represent an additional regulatory layer for the cell type-specific antiviral response.

Indexed as

HistonesInterferon-betaAnimalsAntiviral AgentsChromatinEpigenesis, GeneticHumansMiceAntiviral AgentsChromatinHistonesInterferon-beta

Identifiers

PMID36732019
PMCPMC9900254
OpenAlexW4318975388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.